Crescent Biopharma, Inc. (CBIO)
NASDAQ·Healthcare·Biotechnology
$18.40
+2.51%
Mkt Cap $494.09M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$33.00
Range $29.00 – $35.00
Implied Upside
+79.3%
Consensus $33.00 vs current $18.40
NASDAQ·Healthcare·Biotechnology
$18.40
+2.51%
Mkt Cap $494.09M
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$33.00
Range $29.00 – $35.00
+79.3%
Consensus $33.00 vs current $18.40